Literature DB >> 1392181

Systemic lupus erythematosus with sensorineural hearing loss and improvement after plasmapheresis using the double filtration method.

S Kobayashi1, N Fujishiro, K Sugiyama.   

Abstract

A 32-year-old female was diagnosed as having systemic lupus erythematosus based on her laboratory tests. In 1985 she began to complain of hearing difficulty. Her hearing ability deteriorated to the extent that her audiogram revealed a hearing loss of 90 db to 110 db in both ears in September 1989. She received two series of plasmapheresis treatments using the double filtration method. After two series of plasmapheresis treatments, her hearing improved dramatically. This improvement suggests that circulating immune complexes and anti-phospholipid antibodies might play a pathological role in the hearing impairment in SLE patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392181     DOI: 10.2169/internalmedicine.31.778

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Primary antiphospholipid antibody syndrome: a case with bilateral sudden sensorineural hearing loss.

Authors:  Jian-Gang Wang; Qi-Bing Xie; Nan-Ping Yang; Geng Yin
Journal:  Rheumatol Int       Date:  2008-09-23       Impact factor: 2.631

Review 2.  Systemic Lupus Erythematosus and hearing disorders: Literature review and meta-analysis of clinical and temporal bone findings.

Authors:  A Di Stadio; Massimo Ralli
Journal:  J Int Med Res       Date:  2017-02-20       Impact factor: 1.671

Review 3.  Bilateral sudden sensorineural hearing loss as a presenting feature of systemic lupus erythematosus: Case report and brief review of other published cases.

Authors:  Sylvain Chawki; Jessie Aouizerate; Selim Trad; Jacques Prinseau; Thomas Hanslik
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 4.  Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment.

Authors:  Laura Girasoli; Diego Cazzador; Roberto Padoan; Ennio Nardello; Mara Felicetti; Elisabetta Zanoletti; Franco Schiavon; Roberto Bovo
Journal:  J Immunol Res       Date:  2018-09-26       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.